Neoplasms
1,121
121
169
640
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
219 trials with published results (20%)
Research Maturity
640 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.0%
134 terminated out of 1121 trials
82.7%
-3.9% vs benchmark
6%
69 trials in Phase 3/4
34%
219 of 640 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 640 completed trials
Clinical Trials (1121)
Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'
Safety and Efficacy of Ultrasound-Guided Percutaneous Nephrostomy in Oncology Patients
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Clinical and Genetic Studies of Li-Fraumeni Syndrome
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Difficult Airway Management in Oncology: An International Delphi Consensus Study (DAMO)
HTL0039732 in Participants With Advanced Solid Tumours
Ambient AI Documentation in Oncology Consultations
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
Registry Study for Radiation Therapy Outcomes
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)